366 Federal Register / Vol. 76, No. 2 / Tuesday, January 4, 2011 / Notices 

ADDRESSES: The meeting will be held at 

the Environmental Protection Agency, 

Office of Pesticide Programs (OPP), One 

Potomac Yard (South Building), 4th 

Floor South Conference Room (S–4370/ 

80), 2777 S. Crystal Drive, Arlington, 

VA 22202. 

FOR FURTHER INFORMATION CONTACT: 

Chuck Peck, Environmental Fate and 

Effects Division (7507P), Office of 

Pesticide Programs, Environmental 

Protection Agency, 1200 Pennsylvania 

Ave., NW., Washington, DC 20460– 

0001; telephone number: (703) 347– 

8064; fax number: (703) 305–6309; email address: peck.charles@epa.gov. 

SUPPLEMENTARY INFORMATION: 

I. General Information 

A. Does this action apply to me? 

You may be potentially affected by 

this action if you are required to 

conduct testing of chemical substances 

under the Toxic Substances Control Act 

(TSCA), the Federal Food, Drug, and 

Cosmetic Act (FFDCA), or the Federal 

Insecticide, Fungicide, and Rodenticide 

Act (FIFRA). Since other entities may 

also be interested, the Agency has not 

attempted to describe all the specific 

entities that may be affected by this 

action. If you have any questions 

regarding the applicability of this action 

to a particular entity, consult the person 

listed under FOR FURTHER INFORMATION

CONTACT. 

B. How can I get copies of this document 

and other related information? 

EPA has established a docket for this 

action under docket ID number EPA– 

HQ–OPP–2009–0879. Publicly available 

docket materials are available either in 

the electronic docket at http:// 

www.regulations.gov, or, if only 

available in hard copy, at the Office of 

Pesticide Programs (OPP) Regulatory 

Public Docket in Rm. S–4400, One 

Potomac Yard (South Bldg.), 2777 S. 

Crystal Dr., Arlington, VA. The hours of 

operation of this Docket Facility are 

from 8:30 a.m. to 4 p.m., Monday 

through Friday, excluding legal 

holidays. The Docket Facility telephone 

number is (703) 305–5805. 

II. Background 

On a biannual interval, an Exposure 

Modeling Public Meeting will be held 

for presentation and discussion of 

current issues in modeling pesticide 

fate, transport, and exposure of risk 

assessment in a regulatory context. 

Meeting dates and abstract requests are 

announced through the ‘‘empmlist’’ 

forum on the LYRIS list server at 

https://lists.epa.gov/read/all_forums/. 

III. How can I request to participate in 

this meeting? 

You may submit a request to 

participate in this meeting to the person 

listed under FOR FURTHER INFORMATION

CONTACT. Do not submit any information 

in your request that is considered CBI. 

Requests to participate in the meeting, 

identified by docket ID number EPA– 

HQ–OPP–2009–0879, must be received 

3 days after January 4, 2011. 

IV. Tentative Topics for the Meeting 

Tentative topics for the meeting will 

include presentations related to the 

spatial context of terrestrial exposure 

modeling. Specifically, presentations 

will include the following: 

• Estimation of confidence intervals 

for metabolite degradation rates. 

• Developments in terrestrial 

exposure modeling. 

• Determining the fate and transport 

of pesticides in the Chesapeake Bay 

region. 

• Habitat classification for ecological 

risk assessments using aerial 

photography and GIS data. 

• Dermal contact, movement, and 

amphibian pesticide exposure. 

List of Subjects 

Environmental protection, modeling, 

monitoring, pesticides. 

Dated: December 28, 2010. 

Arthur-Jean Williams, 

Acting Director, Environmental Fate and 

Effects Division, Office of Pesticide Programs. 

[FR Doc. 2010–33202 Filed 1–3–11; 8:45 am] 

BILLING CODE 6560–50–P 

ENVIRONMENTAL PROTECTION 

AGENCY 

[FRL–9247–4] 

Public Water Supply Supervision 

Program; Program Revision for the 

State of Washington 

AGENCY: Environmental Protection 

Agency (EPA). 

ACTION: Notice of tentative approval. 

SUMMARY: Notice is hereby given that 

the State of Washington has revised its 

approved State Public Water Supply 

Supervision Primacy Program. 

Washington has adopted a definition for 

public water system that is analogous to 

EPA’s definition of public water system, 

and has adopted regulations analogous 

to EPA’s Consumer Confidence Report 

Rule, Interim Enhanced Surface Water 

Treatment Rule, Stage 1 Disinfectants 

and Disinfection Byproducts Rule, Lead 

and Copper Minor Revisions Rule, 

Public Notification Rule, Radionuclides 

Rule, Arsenic Rule, Filter Backwash 

Rule, Long Term 1 Enhanced Surface 

Water Treatment Rule, Variance and 

Exemptions Rule, Stage 2 Disinfectants 

and Disinfection Byproducts Rule, Long 

Term 2 Enhanced Surface Water 

Treatment Rule, and Ground Water 

Rule. EPA has determined that these 

revisions are no less stringent than the 

corresponding Federal regulations. 

Therefore, EPA intends to approve these 

State program revisions. By approving 

these rules, EPA does not intend to 

affect the rights of Federally recognized 

Indian Tribes within ‘‘Indian country’’ as 

defined by 18 U.S.C. 1151, nor does it 

intend to limit existing rights of the 

State of Washington. 

DATES: All interested parties may 

request a public hearing. A request for 

a public hearing must be submitted by 

February 3, 2011 to the Regional 

Administrator at the EPA address 

shown below. Frivolous or insubstantial 

requests for a hearing may be denied by 

the Regional Administrator. However, if 

a substantial request for a public hearing 

is made by February 3, 2011, a public 

hearing will be held. If no timely and 

appropriate request for a hearing is 

received and the Regional Administrator 

does not elect to hold a hearing on his 

own motion, this determination shall 

become final and effective on February 

3, 2011. Any request for a public 

hearing shall include the following 

information: (1) The name, address, and 

telephone number of the individual, 

organization, or other entity requesting 

a hearing; (2) a brief statement of the 

requesting person’s interest in the 

Regional Administrator’s determination 

and a brief statement of the information 

that the requesting person intends to 

submit at such hearing; (3) the signature 

of the individual making the request, or, 

if the request is made on behalf of an 

organization or other entity, the 

signature of a responsible official of the 

organization or other entity. 

ADDRESSES: All documents relating to 

this determination are available for 

inspection between the hours of 9 a.m. 

and 4 p.m., Monday through Friday, at 

the Washington Department of HealthOffice of Drinking Water, 243 Israel 

Road SE., 2nd floor, Tumwater, 

Washington 98501 and between the 

hours of 9 a.m.–12 p.m. and 1–4 p.m. at 

the EPA Region 10 Library, 1200 Sixth 

Avenue, Seattle, Washington 98101. 

FOR FURTHER INFORMATION CONTACT: 

Wendy Marshall, EPA Region 10, 

Drinking Water Unit, by mail at the 

Seattle address given above, by 

telephone at (206) 553–1890, or by 

e-mail at marshall.wendy@epa.gov. 


jlentini on DSKJ8SOYB1PROD with NOTICES
Federal Register / Vol. 76, No. 2 / Tuesday, January 4, 2011 / Notices 367 

Authority: Section 1420 of the Safe 

Drinking Water Act, as amended (1996), and 

40 CFR Part 142 of the National Primary 

Drinking Water Regulations. 

Dated: December 22, 2010. 

Dennis J. McLerran, 

Regional Administrator, Region 10. 

[FR Doc. 2010–33192 Filed 1–3–11; 8:45 am] 

BILLING CODE 6560–50–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES (HHS) 

Centers for Disease Control and 

Prevention (CDC) 

Office of State, Tribal, Local and 

Territorial Support (OSTLTS) 

In accordance with Presidential 

Executive Order No. 13175, November 

6, 2000, and the Presidential 

Memorandum of November 5, 2009 and 

September 23, 2004, Consultation and 

Coordination with Indian Tribal 

Governments, CDC, OSTLTS announces 

the following meeting and Tribal 

Consultation Session: 

Name: Tribal Consultation Advisory 

Committee (TCAC) Meeting and 6th Biannual 

Tribal Consultation Session 

Times and Dates: 

8:30 a.m.–5 p.m., February 1–2, 2011 (TCAC 

Meeting) 

8:30 a.m.–5 p.m., February 3, 2011 (6th 

Biannual Tribal Consultation Session) 

Place: CDC, 1600 Clifton Road, NE., 

Building 21, Atlanta, Georgia 30333. 

Status: The TCAC meeting is open to the 

public. Attendance at the Tribal Consultation 

meeting is by special invitation to the 

American Indian/Alaska Native (AI/AN) 

Tribal Leaders from across the nation. 

Visitors must be processed in accordance 

with established federal policies and 

procedures. All visitors are required to 

present a valid form of picture identification 

issued by a state or federal government. The 

meeting room accommodates approximately 

100 people. 

Purpose: CDC released their Tribal 

Consultation Policy in October of 2005 with 

the primary purpose of providing guidance 

across the agency to work effectively with AI/ 

AN tribes, communities, and organizations to 

enhance AI/AN access to CDC resources and 

programs. In November of 2006, an Agency 

Advisory Committee (CDC/Agency for Toxic 

Substances and Disease Registry Tribal 

Consultation Advisory Committee—TCAC) 

was established to provide a complementary 

venue wherein tribal representatives and 

CDC staff have the opportunity to exchange 

information about public health issues in 

Indian Country, identifying urgent public 

health needs in AI/AN communities, and 

discuss collaborative approaches to these 

issues and needs. Within the CDC 

Consultation Policy, it is stated that CDC will 

conduct government-to-government 

consultation with elected tribal officials or 

their designated representatives and also 

confer with AI/AN organizations and AI/AN 

urban and rural communities before taking 

actions and or making decisions that affect 

them. Consultation is designed to be an 

enhanced form of communication that 

emphasizes trust, respect, and shared 

responsibility. It is an open and free 

exchange of information and opinion among 

parties that leads to mutual understanding 

and comprehension. CDC believes that 

consultation is integral to a deliberative 

process that results in effective collaboration 

and informed decision making with the 

ultimate goal of reaching consensus on 

issues. Although formal responsibility for the 

agency’s overall government-to-government 

consultation activities rests within the 

OSTLTS, leadership of other CDC Centers, 

Institutes and Offices shall actively 

participate in TCAC meetings and HHSsponsored regional and national tribal 

consultation sessions as frequently as 

possible. 

Matters to be Discussed: The TCAC will 

convene their advisory committee meeting 

with discussions and presentations by 

various CDC senior leaders on activities and 

areas identified by TCAC members and other 

tribal leaders as priority public health issues. 

The Biannual Tribal Consultation Session 

will engage CDC Senior leadership from the 

Office of the Director and various CDC 

Centers, Institutes and Offices. Opportunities 

will be provided during the consultation 

session for tribal testimony. Tribal Leaders 

are encouraged to submit written testimony 

by close of business on January 15, 2011, to 

the contact person listed below. 

It may be necessary to limit the time of 

each presenter due to the availability of time. 

The agenda is subject to change as 

priorities dictate. 

Information on previous TCAC and Tribal 

Consultation meetings is available at web 

link http://www.cdc.gov/ostlts/ 

tribal_public_health/index.html. 

Contact Person for More Information: 

Kimberly Cantrell, Senior Tribal Liaison for 

Policy and Evaluation, OSTLTS, CDC, 4770 

Buford Highway, MS E–19, Atlanta, Georgia 

30341, telephone (404) 498–0411, e-mail: 

KLW6@cdc.gov. 

The Director, Management Analysis and 

Services Office has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both the Centers for Disease Control and 

Prevention, and the Agency for Toxic 

Substances and Disease Registry. 

Dated: December 27, 2010. 

Andre Tyler, 

Acting Director, Management Analysis and 

Services Office Centers for Disease Control 

and Prevention. 

[FR Doc. 2010–33126 Filed 1–3–11; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Minority HIV/ 

AIDS Research Initiative (MARI) To 

Build Capacity in Black and Hispanic 

Communities and Among Black and 

Hispanic Researchers To Conduct HIV/ 

AIDS Epidemiologic and Prevention 

Research, Funding Opportunity 

Announcement (FOA), PS11–003, 

Initial Review 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting: 

Times and Dates: 

8 a.m.–5 p.m., March 14, 2011 

(Closed) 

8 a.m.–5 p.m., March 15, 2011 

(Closed) 

Place: Sheraton Gateway Hotel 

Atlanta Airport, 1900 Sullivan Road, 

Atlanta, Georgia 30337, Telephone: 

(770)997–1100. 

Status: The meeting will be closed to 

the public in accordance with 

provisions set forth in Section 552b(c) 

(4) and (6), Title 5 U.S.C., and the 

Determination of the Director, 

Management Analysis and Services 

Office, CDC, pursuant to Public Law 92– 

463. 

Matters to be Discussed: The meeting 

will include the initial review, 

discussion, and evaluation of 

applications received in response to 

‘‘Minority HIV/AIDS Research Initiative 

(MARI) to Build Capacity in Black and 

Hispanic Communities and Among 

Black and Hispanic Researchers to 

Conduct HIV/AIDS Epidemiologic and 

Prevention Research, FOA PS11–003, 

initial review.’’ 

Contact Person for More Information: 

Amy Yang, Ph.D., Scientific Review 

Officer, CDC, 1600 Clifton Road, NE., 

Mailstop E60, Atlanta, Georgia 30333, 

Telephone: (404) 498–2733. The 

Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 


jlentini on DSKJ8SOYB1PROD with NOTICES